95
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Assessment of Inflammation with Hematological Parameters in Patients with Migraine and Tension-Type Headache: A Prospective Study from A Tertiary Care Center

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 141-148 | Received 03 May 2021, Accepted 27 Jul 2021, Published online: 25 Aug 2021

References

  • Filler L , AkhterM , NimlosP. Evaluation and management of the emergency department headache. Semin. Neurol.39(1), 20–26 (2019).
  • Ang SH , ChanYC , MahadevanM. Emergency department headache admissions in an acute care hospital: why do they occur and what can we do about it?Ann. Acad. Med. Singap.38(11), 1007–1010 (2009).
  • Friedman BW , HochbergML , EssesDet al. Applying the International Classification of Headache Disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentation. Ann. Emerg. Med.49(4), 409–419 (2007).
  • Peters KS . Secondary headache and head pain emergencies. Prim. Care31(2), 381–393 (2004).
  • Sharma TL . Common primary and secondary causes of headache in the elderly. Headache58(3), 479–484 (2018).
  • Goldstein JN , CamargoCAJr , PelletierAJ , EdlowJA. Headache in United States emergency departments: demographics, work-up and frequency of pathological diagnoses. Cephalalgia26(6), 684–690 (2006).
  • Güloğlu C , DurgunHM. Baş ve yüz ağrılı hastanın acil serviste yönetimi. Turkiye Klinikleri J. Emerg. Med.-Special Topics3(3), 215–221 (2017).
  • Leonardi M , RaggiA. A narrative review on the burden of migraine: when the burden is the impact on people’s life. J. Headache Pain20(1), 41 (2019).
  • Headache Classification Committee of the International Headache Society (IHS) . The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia33(9), 629–808 (2013).
  • Kim BK , ChuMK , LeeTG , KimJM , ChungCS , LeeKS. Prevalence and impact of migraine and tension-type headache in Korea. J. Clin. Neurol.8(3), 204–211 (2012).
  • Burch R . Migraine and tension-type headache: diagnosis and treatment. Med. Clin. North Am.103(2), 215–233 (2019).
  • Russell M , OlesenJ. A nosographic analysis of the migraine aura in a general population. Brain119(2), 355–361 (1996).
  • Viana M , AfridiS. Migraine with prolonged aura: phenotype and treatment. Naunyn Schmiedebergs Arch. Pharmacol.391(1), 1–7 (2018).
  • Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia38(1), 1–211 (2018).
  • Lukacs M , TajtiJ , FulopFet al. Migraine, neurogenic inflammation, drug development – pharmacochemical aspects. Curr. Med. Chem.24(33), 3649–3665 (2017).
  • Bendtsen L , EversS , LindeMet al. EFNS guideline on the treatment of tension-type headache – report of an EFNS task force. Eur. J. Neurol.17(11), 1318–1325 (2010).
  • Bø SH , DavidsenEM , GulbrandsenPet al. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia29(3), 365–372 (2009).
  • Della Vedova C , CathcartS , DohnalekAet al. Peripheral interleukin-1ß levels are elevated in chronic tension-type headache patients. Pain Res. Manag.18(6), 301–306 (2013).
  • Karabulut KU , EgerciogluTU , UyarM , UcarY. The change of neutrophils/lymphocytes ratio in migraine attacks: a case–controlled study. Ann. Med. Surg. (Lond.)10(2016), 52–56 (2016).
  • Moskowitz MA . The neurobiology of vascular head pain. Ann. Neurol.16(2), 157–168 (1984).
  • Spierings EL . Pathogenesis of the migraine attack. Clin. J. Pain19(4), 255–262 (2003).
  • Goadsby PJ . Cortical spreading depression-better understanding and more questions. Focus on distinct vascular conduction with cortical spreading depression. J. Neurophysiol.97(6), 3827 (2007).
  • Lippi G , MattiuzziC , CervellinG. C-reactive protein and migraine. Facts or speculations?Clin. Chem. Lab. Med.52(9), 1265–1272 (2014).
  • Eising E , DatsonNA , vanden Maagdenberg AM , FerrariMD. Epigenetic mechanisms in migraine: a promising avenue?BMC Med.11, 26 (2013).
  • Waeber C , MoskowitzMA. Migraine as an inflammatory disorder. Neurology64(2 Suppl. 10), 9–15 (2005).
  • Turan H , HorasanliB , UgurM , ArslanH. Procalcitonin levels in migraine patients. Can. J. Neurol. Sci.38(1), 124–128 (2011).
  • Ceylan M , BayraktutanOF , BecelSet al. Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: association with migraine characteristics. Cephalalgia36(6), 518–525 (2016).
  • Yilmaz Avci A , LakadamyaliH , ArikanS , BenliUS , KilincM. High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients. J. Headache Pain16, 9 (2015).
  • Sarchielli P , AlbertiA , BaldiAet al. Pro-inflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache46(2), 200–207 (2006).
  • Eryigit U , AltunayogluCV , SahinAet al. Am. J. Emerg. Med. 35(9), 1276–1280 (2017).
  • Bas FY , DemirciS , ArslanB. The relationship between headache features and haematological parameters in migraine patients. Euras. J. Fam. Med.4(2), 53–56 (2015).
  • Damasio H , BeckD. Migraine thrombocytopenia, and serotonin metabolism. Lancet1(8058), 240–242 (1978).
  • Damasio H . Migraine, thrombocytopenia, and serotonin metabolism. Lancet2(8036), 512–513 (1977).
  • Cotrim MD , RibeiroCA , deMacedo Tdos R. Changes in platelet membrane fluidity of migraine patients. Cephalalgia13(2), 99–101 (1993).
  • Taffi R , VigniniA , LanciottiCet al. Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods. Cephalalgia25(5), 353–358 (2005).
  • Vecino AM , Alvarez-CermeñoJC , Jimenez-HueteA , NavarroJL , CesarJM. Lipid composition of platelets in patients suffering from migraine without aura. Headache36(7), 440–441 (1996).
  • De Matteis G , Tozzi-CiancarelliMG , CalissePet al. Platelet changes in classic migraine. Ital. J. Neurol. Sci.14(3), 207–210 (1993).
  • Zeller JA , LindnerV , FrahmK , BaronR , DeuschlG. Platelet activation and platelet–leucocyte interaction in patients with migraine. Subtype differences and influence of triptans. Cephalalgia25(7), 536–541 (2005).
  • Varol S , AkılE , CevikUMet al. Investigation of mean platelet volume and platelet count in the blood of patients with migraine. Turk. J. Neurol.19(3), 90–92 (2013).
  • Peatfield RC , GawelMJ , GuthrieDLet al. Platelet size: no correlation with migraine or monoamine oxidase activity. J. Neurol. Neurosurg. Psychiatry45(9), 826–829 (1982).
  • Pradalier A , AbuafN , LaunayJM , VincentD. Platelet size and volume distribution measured by automated platelet analyzer. Cephalalgia12(5), 321–322 (1992).
  • Fischer M , WilleG , KlienSet al. Brain-derived neurotrophic factor in primary headaches. J. Headache Pain13(6), 469–475 (2012).
  • Özdemir HH , DönderA. Evaluation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and C-reactive protein in tension-type headache patients. J. Neurosci. Rural Pract.12(3), 566–570 (2021).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.